baber/WOPTO huggingface dataset:
Patent GR-1004258-B (GR)
Title: Vessel - supporting structure for emptying vessels
Inventor: VLASTARAKIS NIKOLAOS KONSTANTI
IPC: B65G65/24
Filed: 2002-05-01
Abstract: t is disclosed a supporting base designed to empty vessels. It is composed of a shaped metal frame formed by successively positioned multi-sized plates (3,4,6,7,8,9,10), which are properly perforated to form the system depicted in fig. A. It is characterized in that emptying is achievable with no harsh efforts, the discharged quantity is comfortably controlled, the room that the base occupies is minimal since its volume can be reduced solely with mere movements of the hands - with no tools andin less than a minute- in order to be stored. Furthermore, being integrally connected to the vessel, said base accompanies freely this last even in case of transport or displacement. Thanks to extra holes, it is able to modify the centre of gravity and receive vessels of different size. Moreover, it is provided with an integral piece of noise- and shock-absorbing material stuck on the point 15, a stop for the piece 4 of the vessel bottom, a base for the optional fixing of vessel onto its stepping points; the base in question is optionally screwed on its stepping points in order to be stabilized in boats, trains, cars, airplanes etc. The invented vessel-supporting base is designed for better and comfortable accommodations.
Patent IN-179550-B (IN)
Inventor: GILMORE JEREMY
IPC: A61P1/08
Filed: 1995-09-11
Abstract: A pharmaceutical compound of the formula <CHEM> in which R<1> and R<7> are each halo, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, optionally substituted phenyl, optionally substituted naphthyl or optionally substituted heteroaryl, R<2> and R<3> are each hydrogen or C1-6 alkyl, R<4> and R<5> are each hydrogen, halo, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, optionally substituted phenyl, optionally substituted naphthyl or optionally substituted heteroaryl, R<6> is hydrogen, C1-6 alkyl, optionally substituted phenyl, optionally substituted naphthyl, optionally substituted heteroaryl, optionally substituted phenyl-C1-6 alkyl or -CO2R<8> where R<8> is an ester group, m and p are each 0, 1, 2, 3 or 4, n is 1, 2, 3 or 4, Z is <CHEM> where R<9> and R<1><0> are each hydrogen, C1-6 alkyl or optionally substituted phenyl-C1-6 alkyl, X is oxygen or sulphur, and Y is <CHEM> where R<1><1> and R<1><2> are each hydrogen, C1-6 alkyl, trifluoromethyl, optionally substituted phenyl, optionally substituted naphthyl or optionally substituted heteroaryl;  and salts and solvates thereof. The compounds of the invention are indicated for use in the treatment of diseases of the central nervous system. They are active in tests that indicate serotonergic modulation.
Patent MX-338223-B (MX)
Title: Fat emulsion for artificially feeding seriously ill intensive care patients.
Inventor: BOLL MICHAEL
IPC: A61P3/02
Filed: 2009-11-09
Abstract: The present invention relates to a pharmaceutical preparation for the prophylaxis and treatment of critical illness polyneuropathy (CIP) and critical illness myopathy (CIM). The invention further relates to an isotonic fat emulsion comprising at least one triglyceride that comprises at least one fatty acid group having an odd number of carbon atoms, wherein the fatty acid group comprises a carbon chain having 5 to 15 carbon atoms.
Patent MX-340987-B (MX)
Title: Novel xylose tranporters and their applications thereof.
Inventor: GUILLERMO GOSSET LAGARDA
IPC: C12N9/12
Filed: 2011-08-05
Abstract: Described is a novel transporter for five-carbon sugar best known as xylose, which corresponds to a protein obtained from the Escherichia coli bacterium, also referring to the DNA encoding for said protein (gene gatC, SEQ. ID NO: 13) and mutant protein with a better transport capacity (gen gatCS184L, SEQ. ID NO: 14). The present invention shows the capacity of the protein GatC (SEQ. ID NO: 15) for transporting xylose. Present is a mutant protein which transforms a Serine into a Leucine, a polar amino acid into a non polar amino acid, in the amino acid 184 (GatCS184L, SEQ. ID NO: 16) the improved capacity thereof to transport xylose is shown. As a consequence of the need of xylose transporting proteins that are energetically favourable, the present invention suggests the use of the product resulting from the genes gatC (SEQ. ID NO: 13) and gatCS184L (SEQ. ID NO: 14) as transporters in organisms searching the property of xylose transport or the improvement thereof for the utilization of said organism in the conversion of xylose-rich syrups, such as those obtained in the lignocelluloses hydrolysis as a raw material.
Patent MX-338274-B (MX)
Title: Handheld charge indicator assemblies for use with children's ride-on vehicles, children's ride-on vehicle kits including the same, and methods of determining the state of charge of a battery assembly of a children's ride-on vehicle.
Inventor: BERGUM MARK J
IPC: G08B21/00
Filed: 2010-09-23
Abstract: Handheld charge indicator assemblies, children's ride-on vehicle kits including the same, and methods of determining the state of charge of a battery assembly of a children's ride-on vehicle. Handheld charge indicator assemblies are sized to be held in the hand of a user and are configured to be selectively interconnected to a battery assembly of a children's ride-on vehicle and output an output signal representative of a voltage of the battery assembly. Handheld charge indicator assemblies include a body, an electronic circuit housed within the body, an indicator configured to output an output signal representative of an input voltage to the electronic circuit, and a battery connector configured to engage the battery assembly of a children's ride-on vehicle. In some embodiments, the handheld charge indicator assembly further includes an actuator configured to actuate the electronic circuit to detect the input voltage responsive to a user engaging the actuator.
Patent MX-348567-B (MX)
Title: Fusion protein having factor vii activity.
Inventor: HO-SOON LEE
IPC: C12N15/62
Filed: 2011-06-07
Abstract: A fusion protein comprising factor VII (FVII) and transferrin according to the present invention has an improved specific activity of FVII compared to existing FVII fusion proteins comprising other fusion partners than transferrin, and thus can be effectively used in a therapy using FVII.
Patent MX-362064-B (MX)
Title: Subsea hydrocarbon production system.
Inventor: KARL-ATLE STENEVIK
IPC: E21B33/035
Filed: 2010-05-28
Abstract: A subsea oil and/or gas production system comprises a host production facility (15) and a plurality of subsea wells (19, 20, 21). A fluid conveying network is provided that connects each subsea well to the host production facility. A separate electrical power and data network is provided for conveying direct current electrical power and data, operatively connected to each subsea well for providing each subsea well with data transfer and electrical power services. The use of direct current ensures that the electrical power and data network can provide power over much greater distances than currently available, and the use of separate networks for conveying fluids and for providing electrical power and data transfer allows for a much more flexible system.
Patent MX-340101-B (MX)
Title: Novel anti-cmet antibody.
Inventor: LILIANE GOETSCH
IPC: A61K39/395
Filed: 2011-06-01
Abstract: The present invention relates to a novel divalent antibody capable of binding specifically to the human c-Met receptor and/or capable of specifically inhibiting the tyrosine kinase activity of said receptor, preferably both in a ligand-dependent and in a ligand-independent manner as well as the amino acid and nucleic acid sequences coding for said antibody. More preferably said antibody comprises a modified hinge region and exhibits an improved antagonistic activity. More particularly, the antibody according to the invention is capable of inhibiting the c-Met dimerization. The invention likewise comprises the use of said antibody as a medicament for the prophylactic and/or therapeutic treatment of cancers, preferably for cancer characterized by a ligand- independent activation of c-Met,or any pathology connected with the over expression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the over-expression of c-Met. The invention finally comprises products and/or compositions comprising such an antibody in combination with other antibodies and/or chemical compounds directed against other growth factors involved in tumor progression or metastasis and/or compounds and/or anti-cancer agents or agents conjugated with toxins and their use for the prevention and/or the treatment of certain cancers.
Patent MX-338605-B (MX)
Title: Bisaryl (thio)morpholine derivatives as s1p modulators.
Inventor: IWEMA BAKKER WOUTER I
IPC: A61K31/5377
Filed: 2011-07-08
Abstract: The present invention relates to bisaryl (thio)morpholine derivatives of the formula (I) wherein R1 is an aryl substitutent selected from phenyl, pyridyl, pyrimidinyl, biphenyl and naphthyl, each optionally substituted with one or more substituents independently selected from halogen, (1-6C)alkyl optionally substituted with one or more fluoro atoms, (1-4C)alkoxy optionally substituted with one or more fluoro atoms, amino, di(1-4C)alkylamino, -SO2-(1-4C)alkyl, -CO-(1-4C)alkyl, -CO-O-(1-4C)alkyl and -NH-CO-(1-4C)alkyl, or substituted with phenoxy, benzyl, benzyloxy, phenylethyl or morpholinyl, each optionally substituted with (1-4C)alkyl, and (8-10C)bicyclic group, bicyclic heterocycle, each optionally substituted with (1-4C)alkyl optionally substituted with one or more fluoro atoms or oxo; A is selected from -CO-, -NH-, -O-, -S-, -SO- or -SO2-; ring structure B optionally contains one nitrogen atom; R2 is H, (1-4C)alkyl optionally substituted with one or more fluoro atoms, (1-4C)alkoxy optionally substituted with one or more fluoro atoms, or halogen; and R3 is (1-4C)alkylene-R6 wherein the alkylene group may be substituted with (CH2)2 to form a cyclopropyl moiety or with one or more halogen atoms, or R3 is (3-6C)cycloalkylene-R5 or -CO-CH2-R6, wherein R6 is -OH, -PO3H2, -OPO3H2, -COOH, -COO(1-4C)alkyl or tetrazol-5-yl; R4 is H or (1-4C)alkyl; R5 is one or more substituents independently selected from H, (1-4C)alkyl or oxo; W is -O-, -S-, -SO- or -SO2-; or a pharmaceutically acceptable salt, a solvate or hydrate thereof, with the proviso that the derivative of formula (I) is not 2-[4-(4-chlorophenoxy)-2-chloro-phenyl]-4-morpholineethanol. The compounds of the invention have affinity to S1P receptors and may be used in the treatment, alleviation or prevention of S1P receptor mediated diseases and conditions.
Patent MX-344839-B (MX)
Title: High strength, high toughness steel alloy.
Inventor: PAUL M NOVOTNY
IPC: C22C38/44
Filed: 2012-01-30
Abstract: A high strength, high toughness steel alloy is disclosed. The alloy has the following weight percent composition. Element C 0.30-0.47 Mn 0.8-1.3 Si 1.5-2.5 Cr 1.5-2.5 Ni 3.0-5.0 Mo + ½ W 0.7-0.9 Cu 0.70-0.90 Co 0.01 max. V + (5/9) x Nb 0.10-0.25 Ti 0.005 max. Al 0.015 max. Fe Balance Included in the balance are the usual impurities found in commercial grades of steel alloys produced for similar use and properties including not more than about 0.01% phosphorus and not more than about 0.001% sulfur. Also disclosed is a hardened and tempered article that has very high strength and fracture toughness. The article is formed from the alloy having the weight percent composition set forth above. The alloy article according to this aspect of the invention is further characterized by being tempered at a temperature of about 500°F to 600°F.
Patent MX-342647-B (MX)
Title: Method for solid waste separation and processing.
Inventor: MARTIN RICHARD GRAVETT
IPC: B03C3/017
Filed: 2012-09-06
Abstract: A method for solid waste separation and processing (10) comprising the method steps of: (a) Passing a municipal solid waste (12) to a first size based separation step (14) producing at least a fine organic fraction(16) and a coarse fraction (18); (b) Passing the fine organic fraction (16) to a digestion process (20) by way of a glass and grit separation step (24); and (c) Recirculating the coarse fraction (18) of step (a) through the first size based separation step (14) at least once.
Patent MX-338407-B (MX)
Title: Twisting device.
Inventor: STIER MARTIN
IPC: H01B13/02
Filed: 2012-11-09
Abstract: The invention relates to a twisting device (1) for twisting electric or optical lines (2), such as wires, cables, line bundles, optical fibers, etc., comprising a base (5) and a first twisting head (3) which can be rotated relative to the base (5) and which is designed to grip the lines (2) to be twisted at a first end of the lines. The invention is characterized in that the twisting device (1) has a second twisting head (4) which can be rotated relative to the base (5), which is arranged opposite the first twisting head (3), and which is designed to grip the lines (2) to be twisted at a second end of the lines, said second end lying opposite the first end. The second twisting head (4) can be rotated in the opposite direction of the first twisting head (3). The invention also relates to a method for twisting lines.
Patent MX-347540-B (MX)
Title: Automatic door system with door system user interface.
Inventor: BRAVERMAN JONATHAN M
IPC: E05F15/70
Filed: 2012-11-20
Abstract: An automatic door system includes a door controller having a plurality of door operation modes. A door driver mechanism is electrically coupled to the door controller, and operatively coupled to a door. A door system user interface is communicatively coupled to the door controller. The door system user interface has a processor unit configured to store a plurality of door operation schedules, with each door operation schedule having an execution date, an execution time, and a door operation mode of the plurality of door operation modes. The processor unit is configured to execute program instructions to: monitor a current date and time; select as an active operation schedule the door operation schedule having the execution date and the execution time that corresponds to the current date and the current time, and select at the door controller the door operation mode corresponding to that of the active operation schedule.
Patent MX-355894-B (MX)
Title: Steel sheet, plated steel sheet, method for producing steel sheet, and method for producing plated steel sheet.
Inventor: KAZUAKI NAKANO
IPC: C23C2/28
Filed: 2013-02-07
Abstract: This steel sheet contains, in mass%, from 0.020% to 0.080% (inclusive) of C, from 0.01% to 0.10% (inclusive) of Si, from 0.80% to 1.80% (inclusive) of Mn and more than 0.10% but less than 0.40% of Al, and additionally contains from 0.005% to 0.095% (inclusive) of Nb and from 0.005% to 0.095% (inclusive) of Ti so that the total of Nb and Ti is from 0.030% to 0.100% (inclusive). The metal structure of this steel sheet is composed of ferrite, bainite and other phases; the area ratio of the ferrite is from 80% to 95%; and the area ratio of the bainite is from 5% to 20%. The total of the fractions of the other phases is less than 3%. This steel sheet has a tensile strength of 590 MPa or more and a fatigue strength ratio of 0.45 or more, said fatigue strength ratio being the fatigue strength relative to the tensile strength.
Patent MX-344444-B (MX)
Title: Surface-coated aluminum-containing galvanized steel sheet and method for producing same.
Inventor: HIROSHI KANAI
IPC: C09D7/61
Filed: 2013-02-28
Abstract: This surface-coated aluminum-containing galvanized steel sheet is obtained by forming a composite coating film that contains a water-dispersible resin (A) and a cobalt compound (B) by applying an aqueous surface treatment agent, which contains the water-dispersible resin (A), the cobalt compound (B) and water and has a pH within the range of 7.5-10, to a plated steel sheet and drying the agent thereon. The constituent ratio by mass of the water-dispersible resin (A) in the composite coating film is 90% or more. The dry mass of the composite coating film per one surface of the plated steel sheet is within the range of 0.5-3.5 g/m2.
Patent MX-347995-B (MX)
Title: Hybrid emitter all back contact solar cell.
Inventor: PAUL LOSCUTOFF
IPC: H01L31/0224
Filed: 2013-12-17
Abstract: An all back contact solar cell has a hybrid emitter design. The solar cell has a thin dielectric layer (102) formed on a backside surface of a single crystalline silicon substrate (101). One emitter (103) of the solar cell is made of doped polycrystalline silicon that is formed on the thin dielectric layer (102). The other emitter (108) of the solar cell is formed in the single crystalline silicon substrate (101) and is made of doped single crystalline silicon. The solar cell includes contact holes that allow metal contacts (107) to connect to corresponding emitters (108, 103).
Patent MX-366400-B (MX)
Title: Novel insulin analog and use thereof.
Inventor: KIM DAE JIN
IPC: C07K19/00
Filed: 2014-02-26
Abstract: The present invention relates to: an insulin analog, wherein the insulin titer is reduced compared with a natural form and the binding force to an insulin receptor is reduced in order to increase the half-life of insulin in the blood; a conjugate, wherein the insulin analog and a carrier are connected; an extended release preparation containing the conjugate; and a method for preparing the conjugate.
Patent MX-339582-B (MX)
Title: Systems and methods for mobile and/or modular manufacturing.
Inventor: KARIN S GAISER
IPC: B29C45/10
Filed: 2008-09-22
Abstract: Systems and methods for manufacturing that are scaleable and de-scaleable based upon the production requirements of the customer's manufacturing facility. Systems and methods for mobile and/or modular manufacturing positioned at or near a customer's production facility that are scaleable and de-scaleable based upo n the production requirements of the customer's manufacturing facility. The system s and methods of manufacturing may include identifying a customer's production requirements at the customer's production facility, designing a manufacturin g cell based upon the identified production requirements, delivering components for the manufacturing cell to a location at or near the customer's production facility, assembling the components to form the manufacturing cell at the location, and training operational personnel to operate the manufacturing cell. The systems and methods may comprise using a modular preform mold system.
Patent MX-370093-B (MX)
Title: Protective guardrail for roads.
Inventor: JOSE MANUEL SÁNCHEZ DE LA CRUZ
IPC: E01F9/669
Filed: 2013-11-25
Abstract: The guardrail, which may take the form of various types of guardrails, is noteworthy in that it includes an impact detector/indicator, for indicating the location of the guardrail involved in an impact or accident and also for notifying the accident and the place where it occurred to a traffic control station or to public assistance personnel. The detector/indicator includes a convex protective plate (2) attached to the front of the guardrail (1) with which it is used, said plate (2) protecting a connection box (3) and a tube (4) so as together to create a means for detecting and communicating the impact that occurred, also having an indicator light (5) for flagging up the impact, said indicator (5) being positioned on a support plate (6) secured above the protective plate (2).
Patent MX-367420-B (MX)
Title: Methods and compositions for inhibition of bromodomain-containing proteins.
Inventor: HARIPRASAD VANKAYALAPATI
IPC: A61P31/18
Filed: 2014-03-13
Abstract: The present invention relates to compounds that bind to and otherwise modulate the activity of bromodomain-containing proteins, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders.
Patent MX-355831-B (MX)
Title: NOVEL CRYSTALLINE HYDRATES OF 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3- [5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE.
Inventor: LOVRO SELIC
IPC: C07D409/10
Filed: 2014-05-07
Abstract: The present invention relates to non-stoichiometric crystalline hydrates of 1-(ß-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thieny lmethyl]benzene, processes for their preparation, and their use as medicaments. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of the novel crystalline hydrates.
Patent MX-362180-B (MX)
Title: Solvent methods for preparing crystalline macrolide particulates, compositions, and articles containing particulates.
Inventor: JORAM SLAGER
IPC: A61M25/10
Filed: 2014-06-12
Abstract: The invention provides therapeutic particulates including a macrolide, such as rapamycin, in solid state crystalline form, having a size of 20 µm or less, or 10 µm or less. The particulates are formed in one method by preparing a composition with a macrolide and first (e.g., xylene) and second (e.g., an alcohol, acetone, or acetonitrile) solvents. In the composition a maximum solubility for the macrolide that is greater than a maximum solubility of the macrolide dissolved in either the first or second solvent individually. The first and second solvents are then evaporated from the composition to provide the macrolide particulates. In another method, the particulates can be formed by a method including sonication and stirring/evaporation steps, and the particulates can be obtained from a supersaturated solution, formed during the process. Particulates display desirable low polydispersity, and can be used in therapeutic compositions, or can be associated with an implantable or insertable medical device for the treatment of a subject.
Patent MX-362154-B (MX)
Title: Electrolytic enrichment method for heavy water.
Inventor: AKIYOSHI MANABE
IPC: C01B5/02
Filed: 2014-07-24
Abstract: An electrolytic enrichment method for heavy water includes enriching heavy water by electrolysis using an alkaline water electrolysis cell including an anode chamber that holds an anode, a cathode chamber that holds a cathode, and a diaphragm. In the method, an electrolyte prepared by adding high-concentration alkaline water to raw material water containing heavy water is circularly supplied to the anode chamber and the cathode chamber from a circulation tank; an anode-side gas-liquid separator and an anode-side water-seal device are connected to the anode chamber, and a cathode-side gas-liquid separator and a cathode-side water-seal device are connected to the cathode chamber; and electrolysis is continued while the alkali concentration in the electrolyte supplied to both electrolysis chambers is maintained at a constant concentration by circularly supplying, to the circulation tank, the electrolyte from which the gas generated from the anode-side gas-liquid separator and the cathode-side gas-liquid separator is separated.
Patent MX-351205-B (MX)
Title: Resistance spot welding method.
Inventor: CHIKAUMI SAWANISHI
IPC: B23K11/11
Filed: 2014-09-12
Abstract: In order to obtain nuggets having an appropriate diameter without expulsion occurring, even under special welding conditions, this resistance spot welding method for bonding a material to be welded having a plurality of overlapping metal plates performs adaptive control welding whereby: a conductive pattern is separated into at least two steps before welding; main welding is started using as a reference therefor a temporal change curve for instantaneous heat generation amount per unit volume obtained by test welding; and, if the temporal change amount for the instantaneous heat generation amount deviates from the reference temporal change curve during any step, the difference is compensated for during the remaining conductive time in that step and the conduction amount is controlled such that the cumulative heat generation amount during main welding matches the cumulative heat generation amount found beforehand by test welding. Said at least two steps comprise: a step for securing a conduction path directly below an electrode; and a step for successively forming nuggets having a prescribed diameter.